CrunchBase is hiring! Check out our open positions →
Register | Login or

General Information

Websitexseedcap.com
Phone(650) 234-4870
Email
Employees2
Founded2006
DescriptionSeed Stage VC focused on clean tech

Funds

Fund II, 4/12 $60M

Offices

Menlo Park, USA
3000 Sand Hill Road Building One, Suite 190
Menlo Park, CA, 94025
USA

People

General Partner
Partner
General Partner

Former People

Venture Partner

Tags

X/Seed Capital

X/Seed Capital is a financial organization. Nothing is publicly known about the organization other than this announcement

Milestones

Investments

Company Date Round Size Participants
Zipline Medical 4/12Series B$5M2
GeneWeave Biosciences 2/12Series A$12M3
ShopSocial 1/11Series A$1.2M2
VitaPath Genetics 11/09Series A$6M2
OPX Biotechnologies 4/09Series C$17.5M4
Solexant 10/08Series B$18.2M4
Solexant 8/07Series A$4.3M4

Videos

Sources

  1. No Returns, No Problem: X/Seed Closes Fund II At More Than $60M (fis.dowjones.com) [edit]
  2. ZipLine Medical announces appointment of John R. Tighe as CEO (ziplinemedical.com) [edit]
  3. GeneWeave Biosciences Attracts $12 Million in Venture Capital in Round Financed by Decheng Capital, Claremont Creek Ventures and X/Seed Capital Capital Will Be Used to Complete the Development and Commercialization of the Company's First Molecular Diagnos (live-pr.com) [edit]
  4. ShopSocial Raises $1.2 Million For Its “Commerce As A Social Service” Idea (techcrunch.com) [edit]
  5. VitaPath Genetics, Inc. Series A $6M (onbiovc.com) [edit]
  6. OPX Biotech Raises $17.5 Million (pehub.com) [edit]
  7. Solexant Corp receives a $18.17 million investment (dealipedia.com) [edit]
  8. Solexant raises $4.3M for new thin film solar cell (deals.venturebeat.com) [edit]
Edit This Page
Last Edited 4/10/12

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

TechCrunch Posts TechCrunch Logo Small Picture

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy